Near eradication of clinically relevant concentrations of human tumor cells by interferon-activated monocytes in vitro

Journal of Interferon and Cytokine Research

Volumn 31, Issue 7, 2011, Pages 569-573

  Baron, Samuel ^a,b   Finbloom, Joel ^a   Horowitz, Julie ^a   Bekisz, Joseph ^a   Morrow, Angel ^a   Zhao, Tongmao ^a   Fey, Samuel ^a   Schmeisser, Hana ^a   Balinsky, Corey ^a   Miyake, Kotaro ^a   Clark, Christopher ^a   Zoon, Kathryn ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON;

ARTICLE; CANCER CONTROL; CELL DEATH; CELL THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; ERADICATION THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; TUMOR CELL; TUMOR CELL LINE;

CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DRUG DOSAGE CALCULATIONS; HUMANS; INTERFERON-ALPHA; MONOCYTES, ACTIVATED KILLER; NEOPLASMS;

EID: 79960131430     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2010.0153     Document Type: Article

References (34)

1. An T, Sood U, Pietruk T, Cummings G, Hashimoto K, Crissman JD. 1987. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters. Am J Pathol 128:52-60. (Pubitemid 17094335)
2. Baron S, Hernandez J, Bekisz J, Poast J, Goldman N, Clouse K, Fields K, Bacot S, Wang J, Zoon K. 2007. Clinical model: interferons activate human monocytes to an eradicative tumor cell level in vitro. J Interferon Cytokine Res 27:157-163. (Pubitemid 46294438)
3. Bekisz J, Baron S, Balinsky C, Morrow A, Zoon KC. 2010. Antiproliferative properties of type I and type II interferon. Pharmaceuticals (Basel) 3:994-1015.
4. Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC. 2004. Human interferons alpha, beta and omega. Growth Factors 22:243-251. (Pubitemid 40123402)
5. Chen AR, Koren HS. 1985. Impaired oxidative burst does not affect human monocyte tumoricidal activity. J Immunol 134:1909-1913. (Pubitemid 15128959)
6. Chen Y, Hoecker P, Zeng J, Dettke M. 2008. Combination of Cobe AutoPBSC and Gambro Elutra as a platform for monocyte enrichment in dendritic cell (DC) therapy: clinical study. J Clin Apher 23:157-162.
7. Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. 2006. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 80:1183-1196. (Pubitemid 44904956)
8. Drysdale BE, Agarwal S, Shin HS. 1988. Macrophage-mediated tumoricidal activity: mechanisms of activation and cytotoxicity. Prog Allergy 40:111-161. (Pubitemid 18052424)
9. Faradji A, Bohbot A, Frost H, Schmitt-Goguel M, Siffert JC, Dufour P, Eber M, Lallot C, Wiesel ML, Bergerat JP, and others. 1991a. Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis. J Clin Oncol 9:1251-1260.
10. Faradji A, Bohbot A, Schmitt-Goguel M, Dumont S, Eischen A, Wiesel ML, Stierle A, Follea G, Eber M, Bergerat JP, and others. 1991b. Apheresis-elutriation program for adoptive immunotherapy with autologous activated monocytes in cancer patients. Int J Artif Organs 14:304-312.
11. Galligioni E, Quaia M, Spada A, Favaro D, Santarosa M, Talamini R, Monfardini S. 1993. Activation of cytolytic activity in peripheral blood monocytes of renal cancer patients against non-cultured autologous tumor cells. Int J Cancer 55:380-385. (Pubitemid 23300583)
12. Gresser I. 1982. How does interferon inhibit tumour growth? Philos Trans R Soc Lond B Biol Sci 299:69-76.
13. Hossne NA, Jr., Invitti AL, Buffolo E, Azevedo S, Rodrigues de Oliveira JS, Stolf NG, Cruz LE, Sanberg PR. 2009. Refractory angina cell therapy (ReACT) involving autologous bone marrow cells in patients without left ventricular dysfunction: a possible role for monocytes. Cell Transplant 18:1299-1310.
14. Isaacs A. 1963. Foreign nucleic acids. Sci Am 209:46-50.
15. Khammari A, Nguyen JM, Pandolfino MC, Quereux G, Brocard A, Bercegeay S, Cassidanius A, Lemarre P, Volteau C, Labarriere N, and others. 2007. Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Cancer Immunol Immunother 56:1853-1860. (Pubitemid 47313089)
16. Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK. 2006. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy. Cancer 107:1407-1418. (Pubitemid 44452792)
17. Kopper L, Lapis K. 1985. Whats new in macrophage-tumor cell interaction? Pathol Res Pract 179:652-655. (Pubitemid 15056365)
18. Manna PP, Mohanakumar T. 2002. Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro. J Leukoc Biol 72:312-320.
19. Martinet N, Beck G, Bernard V, Plenat F, Vaillant P, Schooneman F, Vignaud JM, Martinet Y. 1992. Mechanism for the recruitment of macrophages to cancer site. In vivo concentration gradient of monocyte chemotactic activity. Cancer 70:854-860.
20. Mocellin S, Wang E, Marincola FM. 2001. Cytokines and immune response in the tumor microenvironment. J Immunother 24:392-407. (Pubitemid 33029909)
21. Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, Haruma K, Chayama K. 2003. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 22:773-778.
22. Otten MA, Rudolph E, Dechant M, Tuk CW, Reijmers RM, Beelen RH, van de Winkel JG, van Egmond M. 2005. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J Immunol 174:5472-5480. (Pubitemid 40593187)
23. Pak CC, Fidler IJ. 1991. Molecular mechanisms for activated macrophage recognition of tumor cells. Semin Cancer Biol 2:189-195.
24. Papadopoulou C, Corrigall V, Taylor PR, Poston RN. 2008. The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques. Cytokine 43:181-186.
25. Ruth JH, Park CC, Amin MA, Lesch C, Marotte H, Shahrara S, Koch AE. 2010. Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis. Arthritis Res Ther 12:R118.
26. Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C, Matsushima K, Herlyn M. 2003. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 103:335-343. (Pubitemid 36076426)
27. Shi J, Ikeda K, Fujii N, Kondo E, Shinagawa K, Ishimaru F, Kaneda K, Tanimoto M, Li X, Pu Q. 2005. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells. Cancer Sci 96:127-133. (Pubitemid 40425389)
28. Shieh YS, Hung YJ, Hsieh CB, Chen JS, Chou KC, Liu SY. 2009. Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands. Ann Surg Oncol 16:751-760.
29. Sugiyama T, Gursel M, Takeshita F, Coban C, Conover J, Kaisho T, Akira S, Klinman DM, Ishii KJ. 2005. CpG RNA: identification of novel single-stranded RNA that stimulates human CD14 + CD11c + monocytes. J Immunol 174:2273-2279. (Pubitemid 40223975)
30. Tsuno T, Mejido J, Zhao T, Schmeisser H, Morrow A, Zoon KC. 2009. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha. J Immunother 32:803-816.
31. Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. 1991. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51:3062-3066.
32. Vanderheyde N, Vandenabeele P, Goldman M, Willems F. 2004. Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells. Immunol Lett 91:99-101. (Pubitemid 38296365)
33. Wojtowicz-Praga S. 1997. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 20:165-77. (Pubitemid 28011544)
34. Yamashiro S, TakeyaM, Nishi T, Kuratsu J, Yoshimura T, Ushio Y, Takahashi K. 1994. Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol 145:856-867. (Pubitemid 24320603)